[1]
“Clinical lasting response of crizotinib in ALK positive lung squamous cell carcinoma with brain metastasis”, Eur J Oncol, vol. 22, no. 2, pp. 95–97, Nov. 2017, Accessed: Jul. 18, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4800